The Effect of STW5 (Iberogast) on Reflux Symptoms in Patients With Concurrent Dyspeptic Symptoms: A Double-blind Randomized Placebo-controlled Crossover Trial

CONCLUSIONS: We found some indications pointing towards a beneficial effect of STW5 on reflux symptoms in dyspeptic patients, with reduction of esophageal hypersensitivity as a potential underlying mechanism. Our findings will have to be confirmed in larger studies.PMID:38043927 | DOI:10.5056/jnm23014

Source: Journal of Neurogastroenterology and Motility - December 3, 2023 Category: Gastroenterology Authors: Renske A B Oude Nijhuis Thijs Kuipers Jac M Oors Thomas V K Herregods Boudewijn F Kessing Jeroen M Schuitenmaker Andreas J P M Smout Albert J Bredenoord Source Type: research